We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Is Clover Health (CLOV) the next meme stock worth buying shares in?

Jonathan Smith explains how the online retail investing community is pushing up Clover Health shares, but also why he won’t be investing.

| More on:

You’re reading a free article with opinions that may differ from The Twelfth Magpie’s Premium Investing Services. Become a member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more, and get a free 'Best Buy Now' stock!.

A couple of years ago, talking to someone about a meme stock would have produced a rather puzzled look. It simply wasn’t a phrase that people knew. Fast forward to today, and hoards of retail investors are trying to find what will be the next meme stock. It relates to the surge in stock interest from internet chat sites and social media platforms. Clover Health Investments (NASDAQ:CLOV) shares rallied last week for this reason in particular.

What is Clover Health?

Putting aside the fuel from the army of those on internet chat sites, let’s consider Clover Health in the cold light of day. The company is a US-based Medicare plan provider. Its insurance is mostly for the Southern states, including South Carolina, Tennessee and Texas.

Should you buy Clover Health Investments, Corp. shares today?

Before you decide, please take a moment to review this report first. Despite ongoing uncertainties from US tariffs to global conflicts, Mark Rogers and his team believe many UK shares still trade at substantial discounts, offering savvy investors plenty of potential opportunities to learn about.

That’s why this could be an ideal time to secure this valuable research – Mark’s analysts have scoured the markets to reveal 5 of his favourite long-term ‘Buys’. Please, don’t make any big decisions before seeing them.

The business has performed well recently, which is one reason to support Clover Health shares moving higher. In the 2020 results that were released in March, total revenue grew 46% year-on-year.

It measures success via the membership numbers it has. On this metric, it had a membership of 58,056 as of the end of 2020, a 36.3% increase from 2019. 

Indeed, the potential for further growth was one of the reasons that Clover Health shares can be traded today. Via a reverse merger with successful businessman Chamath Palihapitiya, the business went public last year. The vehicle (known as a SPAC) that was used to get Clover public is becoming increasingly popular for large investors who see value in other businesses.

Should I buy Clover Health shares?

So I’ve established that the company is well grounded and that Mr Palihapitiya saw enough value in it to take it public via a SPAC. How does the meme crowd get involved?

This is slightly harder to explain as there’s no set criteria for the type of stock that such retail investors go after. Some look at stocks that are heavily shorted. Shorting a stock is when an investor thinks the share price will fall. It involves borrowing the stock from a third party, selling it and then looking to buy it back at a lower price. But if the share price rises and the loss is high, the investor would have to buy back the stock and return it to whoever they borrowed it from. This bumps the price up even further.

As was seen with heavily shorted stocks like GameStop, pushing the price higher can trigger an even larger move as those who are ‘short’ have to buy back the stock.

What this meant for Clover Health shares was a move from around $9 at the start of June to a price of $15 now, with highs above $22 last week. Interestingly, last Tuesday, over $14bn worth of stock was traded, an amount larger than the market capitalisation of the company!

I personally wouldn’t buy Clover Health shares right now though. I see the rush to buy from the meme stock community as a negative. It’ll distort the fair price of the shares, making it hard for me to tell what the true value is. Volatility is also increasing, which is something I’d rather stay away from.

Don’t get me wrong, I do think the price could go higher from here in the short term. But this will be fuelled by speculation, and it’s not something I want to be involved in.

jonathansmith1 has no position in any of the shares mentioned. The Motley Fool UK owns shares of Clover Health Investments. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

How investing £20k in a Stocks and Shares ISA could generate a £15,815 yearly passive income for life

Harvey Jones shows how a single lump sum invested in a Stocks and Shares ISA can generate a high and…

Read more »

Investing Articles

SH??? Here are 3 cash-covered 7%-yielding FTSE 250 dividend shares with 30+ years of payouts

The FTSE 250 can be a minefield if you don't know what to look for. Mark Hartley breaks down his…

Read more »

Seniors having fun on bicycles in spring landscape
Investing Articles

With a 5.4% yield, 100 shares of this dividend stock could pay £250 of passive income

Our writer thinks this FTSE 250 bank stock still looks great value today, despite skyrocketing 303% over the past five…

Read more »

Landlady greets regular at real ale pub
Investing Articles

By mid-2027, analysts expect £10,000 in Diageo shares to be worth…

Diageo shares have tanked amid concerns over long-term demand for alcohol beverages. Is there the possibility of a rebound in…

Read more »

Wall Street sign in New York City
Investing Articles

UK investors are buying this stunning S&P 500 stock over Microsoft, Netflix and Nvidia. Why?

If you haven't heard of this S&P 500 growth stock yet, you soon will. British investors are keen but Harvey…

Read more »

Overjoyed exited middle aged married couple giving high five, finishing doing domestic paperwork together at home. Euphoric happy older mature spouses celebrating successful investment or purchase.
Investing Articles

How much do you need in an ISA to target a second income of £1,744 a month?

Harvey Jones shows how regular investing in FTSE 100 shares can build a generous second income for retirement, with minimum…

Read more »

Road 2025 to 2032 new year direction concept
Investing Articles

By July 2027, Lloyds shares could turn £5,000 into…

Do Lloyds' shares have what it takes to deliver another spectacular 40%+ gain in the 12 months to July 2027?…

Read more »

Two business people sitting at cafe working on new project using laptop. Young businesswoman taking notes and businessman working on laptop computer.
Investing Articles

Up 1,150%, is it too late to consider buying this soaring penny stock?

This incredible penny stock has skyrocketed 455% year to date! Ben McPoland explores what's going on and whether there's any…

Read more »